Industry Antiseptic Literature Review Does Not Support Benefit – FDA
This article was originally published in The Rose Sheet
Executive Summary
The 155 literature assessments submitted to FDA by the Cosmetic, Toiletry and Fragrance Association to support a clinical benefit from the use of OTC healthcare antiseptics present too broad a variation in methods that "confounds the assessment of the contribution of OTC healthcare antiseptics to infection control," the agency says